BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) June 27, June 28, 2025 2024 GAAP Revenue $ 241.0 $ 235.9 Operating Income $ 14.9 $ 25.7 Net Income $ 4.5 $ 13.8 Diluted EPS $ 0.12 $ 0.38
Related Questions
What guidance, if any, has the management provided for future quarters?
Are there any one‑time charges or unusual items affecting the results?
How does Novanta's Q2 performance compare to its key competitors?
What is driving the decline in operating income compared to the previous quarter?
How will the lower net income and EPS affect the company's valuation?
Is the revenue growth in line with market expectations for the sector?
Will the company’s cash flow generation be sufficient to support its capital allocation plans?
What is the outlook for the company's operating margin moving forward?
What impact might the reduced profitability have on the stock's price momentum?
How might the current results influence analyst sentiment and future ratings?